Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin.
Carlini
P
P
Di Cosimo
S
S
Ferretti
G
G
Papaldo
P
P
Fabi
A
A
Ruggeri
E M
EM
Milella
M
M
Cognetti
F
F
D000328:Adult; D000505:Alopecia / Q000139:chemically induced*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006728:Hormones / Q000097:blood; D006801:Humans; D000077289:Letrozole; D009570:Nitriles / Q000008:administration & dosage / Q000009:adverse effects*; D017697:Premenopause; D014230:Triazoles / Q000008:administration & dosage / Q000009:adverse effects*; D017329:Triptorelin Pamoate / Q000008:administration & dosage / Q000009:adverse effects*
D018931:Antineoplastic Agents, Hormonal; D006728:Hormones; D009570:Nitriles; D014230:Triazoles; D017329:Triptorelin Pamoate; D000077289:Letrozole